During the past decade, Wohl Eye Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wohl Eye Center" are "Bacterial Conjunctivitis" (1 trials), "Blepharitis" (1 trials), "Dry Eye" (1 trials) and "Meibomian Gland Dysfunction" (1 trials). Many other conditions were trialed in "Wohl Eye Center" in a lesser frequency.

Most popular intervention types in "Wohl Eye Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AGN-195263 0.01%" (1 trials), "AGN-195263 0.03%" (1 trials), "AGN-195263 0.1%" (1 trials) and "AGN-195263 Vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wohl Eye Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Wohl Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Wohl Eye Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wohl Eye Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".